Article
Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patients.
European journal of clinical investigation - 1 Dec 2015
Moreno-Muñoz Diana, de la Haba-Rodríguez Juan R, Conde Francisco, López-Sánchez Laura M, Valverde Araceli, Hernández Vanessa, Martínez Antonio, Villar Carlos, Gómez-España Auxiliadora, Porras Ignacio, Rodríguez-Ariza Antonio, Aranda Enrique
Abstract excerpt
BACKGROUND: Currently, there are no predictive biomarkers for anti-angiogenic strategies in cancer, but response to anti-angiogenic drugs is associated with development of hypertension secondary to treatment. Therefore, this study explored the clinical relevance of genetic polymorphisms in some components of the renin-angiotensin system (RAS). MATERIAL AND METHODS: Genomic DNA was isolated from peripheral blood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
